Back to Medicine Index

Bufocort 160 mcg + 4.5 mcg/puff

Inhaler

Generic: Budesonide + Formoterol Fumarate (Inhaler)

Square Pharmaceuticals PLC.

Therapeutic Class: Inhaled Corticosteroid + Long-acting Beta-2 Agonist

Indications

Regular treatment of asthma where a combination of an inhaled corticosteroid and a long-acting bronchodilator is appropriate. Symptomatic treatment of chronic obstructive pulmonary disease (COPD).

Pharmacology

Budesonide is a corticosteroid with anti-inflammatory action in the airways; formoterol is a beta-2 agonist that relaxes bronchial smooth muscle within 1-3 minutes and acts for at least 12 hours. The combination improves symptoms and reduces exacerbations.

Dosage & Administration

Asthma, adult and adolescent 12 years and over: 1-2 inhalations twice daily of 160 mcg + 4.5 mcg. COPD, adult: 2 inhalations twice daily. Rinse the mouth with water after each use.

Side Effects

Oral thrush, hoarseness, throat irritation, headache, tremor and palpitations. Pneumonia may occur in patients with COPD.

Precautions & Warnings

Do not stop suddenly. Use with caution in tuberculosis, heart disease, thyrotoxicosis, diabetes and low blood potassium. Long-term high doses may cause systemic steroid effects; monitor the growth of children.

Contraindications

Hypersensitivity to budesonide, formoterol or any ingredient of the preparation.

Storage Conditions

Store below 30°C, away from light and direct heat. The inhaler canister is pressurised: do not puncture or burn it, even when empty. Keep out of the reach of children.

This information is for reference only. Always consult a qualified doctor or pharmacist before taking any medicine.